90天死亡率未改变纽约州冠状动脉旁路移植术后医院质量评估
该回顾性队列分析比较了2008至2014年纽约州42家成人心脏外科中心的冠状动脉旁路移植术后30天与90天风险标化死亡率。所有医院90天风险标化死亡率均高于30天,但仅3家医院在改用90天指标后异常值分类发生变化,提示90天死亡率对医院绩效评估的附加价值有限。
要点
- 所有医院90天风险标化死亡率均高于30天,中位数分别为3.69%和2.16%。
- 改用90天指标后仅3家医院异常值分类改变:1家改善、2家变差。
- 90天死亡率可能不提供额外价值来评估CABG医院绩效。
核心结论
- 在纽约州2008至2014年CABG队列中,使用90天死亡率仅使少数医院的质量评估发生变化,可能不提供额外价值。
研究设计与样本
- 回顾性队列分析,纳入纽约州42家成人心脏外科中心2008至2014年共72,398例CABG成人患者,比较30天与90天风险标化死亡率。
主要发现
- 所有医院风险标化死亡率从30天到90天均升高,30天中位数2.16%(四分位距0.69%),90天中位数3.69%(四分位距1.00%)。
- 改用90天指标后,3家医院异常值分类改变:1家从符合预期改善为良好,2家从良好变差为符合预期。
关键数值与推荐
- 医院异常值分类基于分层模型预测风险标化死亡率95%置信区间界限判定良好或不良绩效。
- 主要结局为30天至90天异常值分类的机构绩效变化。
临床怎么用
- 在CABG医院质量公开报告中,30天死亡率与90天死亡率对多数医院评估一致,90天指标可能不必要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Publicly reported postoperative 30-day mortality rates are commonly used to compare hospital quality after coronary artery bypass grafting. We sought to determine whether 90-day mortality rates, which are not publicly reported but better capture postdischarge mortality, are a better determinant of hospital performance. METHODS: We performed a retrospective cohort analysis of 30- versus 90-day risk-standardized mortality rates at adult cardiac surgical centers in New York State from 2008 to 2014. Hospitals were classified as good or poor performing outliers at each time point based on the bounds of the 95% confidence interval around each hospital's predicted risk-standardized mortality rates determined via hierarchical models. The primary outcome was change in institutional performance via outlier classification from 30 to 90 days. RESULTS: During the study period, 72,398 adults underwent a coronary artery bypass grafting procedure at 1 of 42 institutions. The risk-standardized mortality rates increased from 30 to 90 days at all institutions, with a median 30-day risk-standardized mortality rate of 2.16% (interquartile range, 0.69%) and median 90-day risk-standardized mortality rate of 3.69% (interquartile range, 1.00%). In using a 90-day instead of a 30-day metric, 3 hospitals changed outlier status. One hospital improved to a good from as expected performer, and 2 worsened to as expected from good performers. CONCLUSIONS: In a cohort of patients who underwent coronary artery bypass grafting surgery from 2008 to 2014 in New York State, use of a 90-day mortality metric resulted in a change in hospital quality assessment for a minority of hospitals. The use of 90-day mortality may not provide additional value when evaluating institutional performance for this population.
引用
- Mittel A, Kim DH, Cooper Z, et al. Use of 90-day mortality does not change assessment of hospital quality after coronary artery bypass grafting in New York State. J Thorac Cardiovasc Surg. 2020. PMID: 32414596. doi:10.1016/j.jtcvs.2020.03.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。